- Home
- AZTA vs ALTM Comparison
AZTA vs ALTM Comparison
Compare AZTA & ALTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZTA
- ALTM
- Stock Information
- Founded
- AZTA 1978
- ALTM 1942
- Country
- AZTA United States
- ALTM Ireland
- Employees
- AZTA N/A
- ALTM N/A
- Industry
- AZTA Industrial Machinery/Components
- ALTM
- Sector
- AZTA Technology
- ALTM
- Exchange
- AZTA Nasdaq
- ALTM Nasdaq
- Market Cap
- AZTA 2.2B
- ALTM 2.6B
- IPO Year
- AZTA 1995
- ALTM N/A
- Fundamental
- Price
- AZTA $48.60
- ALTM $5.02
- Analyst Decision
- AZTA Buy
- ALTM Hold
- Analyst Count
- AZTA 5
- ALTM 17
- Target Price
- AZTA $63.60
- ALTM $5.51
- AVG Volume (30 Days)
- AZTA 1.2M
- ALTM 8.9M
- Earning Date
- AZTA 02-05-2025
- ALTM 11-07-2024
- Dividend Yield
- AZTA N/A
- ALTM N/A
- EPS Growth
- AZTA N/A
- ALTM N/A
- EPS
- AZTA N/A
- ALTM 0.16
- Revenue
- AZTA $656,323,000.00
- ALTM $900,600,000.00
- Revenue This Year
- AZTA N/A
- ALTM $15.47
- Revenue Next Year
- AZTA $6.17
- ALTM $20.61
- P/E Ratio
- AZTA N/A
- ALTM $32.49
- Revenue Growth
- AZTA N/A
- ALTM N/A
- 52 Week Low
- AZTA $38.82
- ALTM $2.19
- 52 Week High
- AZTA $69.16
- ALTM $7.80
- Technical
- Relative Strength Index (RSI)
- AZTA 60.69
- ALTM 45.45
- Support Level
- AZTA $43.97
- ALTM $5.10
- Resistance Level
- AZTA $47.46
- ALTM $5.23
- Average True Range (ATR)
- AZTA 1.88
- ALTM 0.10
- MACD
- AZTA 0.07
- ALTM -0.03
- Stochastic Oscillator
- AZTA 73.56
- ALTM 34.38
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.
About ALTM Arcadium Lithium plc
Arcadium Lithium is a pure-play lithium producer that was formed in the Allkem-Livent merger in January 2024. Arcadium should benefit from increased lithium demand via higher electric vehicle adoption, as lithium is a key component of EV batteries. The company's low-cost lithium carbonate production comes from two brine resources in Argentina. Arcadium also produces spodumene, a hard rock lithium upstream concentrate, from a mine in Australia and operates downstream lithium hydroxide conversion plants in the United States and China.